- Current report filing (8-K)
March 11 2010 - 9:03AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported): March 5, 2010
K-V Pharmaceutical Company
(Exact Name of
Registrant as Specified in Its Charter)
|
|
|
|
|
Delaware
|
|
1-9601
|
|
43-0618919
|
(State or Other Jurisdiction
of Incorporation)
|
|
(Commission
File Number)
|
|
(IRS Employer
Identification No.)
|
|
|
|
One Corporate Woods Drive
Bridgeton, MO
|
|
63044
|
(Address of Principal Executive Offices)
|
|
(Zip Code)
|
Registrants telephone number, including area code: (314) 645-6600
Check the appropriate box below if
the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (
see
General Instruction A.2. below):
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 5.02.
|
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
.
|
(e) Entry into Material Compensatory Arrangement with Thomas S. McHugh
On March 5, 2010, K-V Pharmaceutical Company (the
Company
) entered into an employment agreement (the
Agreement
),
effective as of February 19, 2010, with Thomas S. McHugh, the Companys Interim Chief Financial Officer, Interim Treasurer, Vice President, Finance and Chief Accounting Officer. The Agreement replaces the employment and confidentiality
agreement the Company previously entered into with Mr. McHugh.
The Agreement provides for, among other things, the following:
Term and Compensation
|
|
|
The Agreement has an initial term that ends on December 31, 2011. The term will automatically extend for successive twelve month periods, unless
either Mr. McHugh or the Company provides written notice to the other at least 180 days prior to the expiration of the then current term. In addition, if a change of control (as such term is defined in the Agreement) occurs during the term, the
Agreement will not expire prior to the second anniversary of the date of consummation of the change of control.
|
|
|
|
Mr. McHugh will receive a base salary of $230,000 per annum, which base salary will be reviewed no less frequently than annually and may be
increased at the discretion of the Board or the Committee.
|
|
|
|
During the term, Mr. McHugh will be eligible to receive an annual cash bonus based on performance objectives established by the Committee each
year, provided that the Company, in its discretion, elects to put into effect an annual cash incentive plan or similar policy with respect to any applicable year.
|
Termination
|
|
|
The Company may terminate the Agreement (1) immediately for Cause upon written notice to Mr. McHugh, (2) without Cause upon 30
days written notice or (3) upon Mr. McHughs disability (as defined in the Agreement) upon 30 days advance written notice. Any determination that Mr. McHugh should be terminated for Cause may be made during or after
the term of the Agreement and must be approved by no fewer than sixty-six and two-thirds (66-
2
/
3
) percent of the directors then serving on the Board; provided, however, that if Mr. McHugh is a member of the Board, he will not participate in such vote, and a determination of Cause may be made by
no fewer than sixty-six and two-thirds (66-
2
/
3
)
percent of the remaining directors then serving on the Board.
Cause
is defined as the occurrence of any of the following:
|
|
|
|
commission of a criminal act in respect of Mr. McHughs employment or conviction of, or plea of guilty or no contest to, a felony;
|
|
|
|
willful misconduct, significant dishonesty, gross negligence or breach of fiduciary duty in respect of Mr. McHughs employment; and
|
|
|
|
continuing neglect or failure of Mr. McHugh to perform the duties reasonably assigned to him by the Company and after notice from the Company of
such neglect or failure, Mr. McHughs failure to cure such neglect or failure within 30 days of such notice, provided that Mr. McHugh will be provided only one 30 day cure period for the same neglect or failure.
|
|
|
|
Mr. McHughs employment will terminate automatically upon his death without any further notice or action required.
|
|
|
|
Mr. McHugh may resign from his employment with the Company for
Relocation
, which is defined as the relocation of
Mr. McHughs principal place of employment to a place more than 75 miles from his principal place of employment as of the effective date of the Agreement. In order to invoke a termination for Relocation, Mr. McHugh must provide
written notice to the Company within 90 days of the occurrence of an event that constitutes Relocation, the Company must have 30 days to cure the event and Mr. McHugh must terminate his employment, if at all, within 30 days of the end of the 30
day cure period if the Company has failed to implement a cure.
|
|
|
|
Other than upon Relocation, Mr. McHugh may resign his employment upon giving the Company at least 120 days advance written notice.
|
Payments to Mr. McHugh Upon Termination
|
|
|
In the event that Mr. McHughs employment is terminated by the Company without Cause or by Mr. McHugh upon Relocation, subject to
Mr. McHughs compliance with the provisions of the Agreement and the execution by Mr. McHugh of a general release of claims, as set forth in the Agreement, the Company will pay or provide to Mr. McHugh:
|
|
|
|
continued participation in the Companys plans providing medical, dental, and vision insurance benefits, as applicable, for the 18 month period
following the termination date; provided that, such welfare plan coverage will cease if Mr. McHugh obtains other full time employment providing for comparable welfare plan benefits prior to the expiration of such 18 month period; and
|
|
|
|
the following amount to be paid (1) over a period of 12 months in equal bi-weekly installments, less deductions as required by law, if the
termination occurs prior to a change of control (as defined in the Agreement) or (2) in a lump sum, less deductions as required by law, if the termination occurs within 12 months of a change of control:
|
|
|
|
an amount equal to one times the sum of (x) Mr. McHughs then current base salary plus (y) Mr. McHughs target annual
cash incentive for the then-current year of the term (provided, however, solely for purposes of determining payments following a termination by the Company without Cause or by Mr. McHugh upon Relocation, that in the event the Company has not
adopted an annual cash incentive plan or similar policy with respect to any applicable year, the annual cash incentive for such year will be an amount equal to 25 percent of Mr. McHughs then-current base salary; and, provided further,
that if such termination occurs after the initial term of the Agreement, the average of the annual cash incentive earned by Mr. McHugh for the two calendar years immediately preceding the year of termination will replace target annual
cash incentive).
|
|
|
|
The Agreement also provides that the Company will make a tax gross-up payment to Mr. McHugh under certain circumstances in the event he is
required to pay any excise tax imposed on any amounts or benefits payable in connection with a change of control pursuant to Section 4999 of the Code; provided, however, that in the event the aggregate value of the total amounts and benefits
payable to Mr. McHugh in connection with a change of control exceeds his Parachute Threshold by less than 10%, one or more of the amounts or benefits payable to Mr. McHugh will be reduced so that the aggregate value of such amounts and
benefits is $1.00 less than the Parachute Threshold.
|
Restrictive Covenants
|
|
|
For a period of 36 months immediately following termination, regardless of how, when or why Mr. McHughs employment ends, he may not, among
other things, compete with the Company, solicit the Companys customers or employees or interfere with any of the Companys suppliers, all as more fully described in the Agreement.
|
The foregoing summary of the Agreement does not purport to be complete and is qualified in its entirety by reference to the Agreement, a copy of which is
attached as
Exhibit 10.1
to this Current Report on Form 8-K and is incorporated herein in its entirety by reference.
Item 9.01.
|
Financial Statements and Exhibits
.
|
(d) Exhibits
|
|
|
Exhibit No.
|
|
Description
|
|
|
10.1
|
|
Employment Agreement, dated as of February 19, 2010 by and between the Company and Mr. McHugh *
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
K-V Pharmaceutical Company
|
|
|
By:
|
|
/s/ David A. Van Vliet
|
|
|
David A. Van Vliet
|
|
|
Interim President and Interim Chief Executive Officer
|
|
Date: March 10, 2010
|
EXHIBIT INDEX
|
|
|
Exhibit No.
|
|
Description
|
|
|
10.1
|
|
Employment Agreement, dated as of February 19, 2010 by and between the Company and Mr. McHugh *
|
K V Pharma (NYSE:KV.A)
Historical Stock Chart
From Jun 2024 to Jul 2024
K V Pharma (NYSE:KV.A)
Historical Stock Chart
From Jul 2023 to Jul 2024